Proctor2010 - UCHL1 Protein Aggregation

  public model
Short description

This a model from the article:
Modelling the Role of UCH-L1 on Protein Aggregation in Age-Related Neurodegeneration.
Proctor CJ, Tangeman PJ, Ardley HC. PLoS One. 2010 Oct 6;5(10):e13175 20949132 ,
Abstract:
Overexpression of the de-ubiquitinating enzyme UCH-L1 leads to inclusion formation in response to proteasome impairment. These inclusions contain components of the ubiquitin-proteasome system and α-synuclein confirming that the ubiquitin-proteasome system plays an important role in protein aggregation. The processes involved are very complex and so we have chosen to take a systems biology approach to examine the system whereby we combine mathematical modelling with experiments in an iterative process. The experiments show that cells are very heterogeneous with respect to inclusion formation and so we use stochastic simulation. The model shows that the variability is partly due to stochastic effects but also depends on protein expression levels of UCH-L1 within cells. The model also indicates that the aggregation process can start even before any proteasome inhibition is present, but that proteasome inhibition greatly accelerates aggregation progression. This leads to less efficient protein degradation and hence more aggregation suggesting that there is a vicious cycle. However, proteasome inhibition may not necessarily be the initiating event. Our combined modelling and experimental approach show that stochastic effects play an important role in the aggregation process and could explain the variability in the age of disease onset. Furthermore, our model provides a valuable tool, as it can be easily modified and extended to incorporate new experimental data, test hypotheses and make testable predictions.


To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

In summary, you are entitled to use this encoded model in absolutely any manner you deem suitable, verbatim, or with modification, alone or embedded it in a larger context, redistribute it, commercially or not, in a restricted way or not.


To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.

Format
SBML (L2V4)
Related Publication
  • Modelling the role of UCH-L1 on protein aggregation in age-related neurodegeneration.
  • Proctor CJ, Tangeman PJ, Ardley HC
  • PloS one , 10/ 2010 , Volume 5 , pages: e13175
  • Center for Integrated Systems Biology of Ageing and Nutrition, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom. c.j.proctor@ncl.ac.uk
  • Overexpression of the de-ubiquitinating enzyme UCH-L1 leads to inclusion formation in response to proteasome impairment. These inclusions contain components of the ubiquitin-proteasome system and α-synuclein confirming that the ubiquitin-proteasome system plays an important role in protein aggregation. The processes involved are very complex and so we have chosen to take a systems biology approach to examine the system whereby we combine mathematical modelling with experiments in an iterative process. The experiments show that cells are very heterogeneous with respect to inclusion formation and so we use stochastic simulation. The model shows that the variability is partly due to stochastic effects but also depends on protein expression levels of UCH-L1 within cells. The model also indicates that the aggregation process can start even before any proteasome inhibition is present, but that proteasome inhibition greatly accelerates aggregation progression. This leads to less efficient protein degradation and hence more aggregation suggesting that there is a vicious cycle. However, proteasome inhibition may not necessarily be the initiating event. Our combined modelling and experimental approach show that stochastic effects play an important role in the aggregation process and could explain the variability in the age of disease onset. Furthermore, our model provides a valuable tool, as it can be easily modified and extended to incorporate new experimental data, test hypotheses and make testable predictions.
Contributors
Carole Proctor

Metadata information

is
BioModels Database MODEL0912070000
BioModels Database BIOMD0000000293
isDerivedFrom
BioModels Database BIOMD0000000105
isDescribedBy
PubMed 20949132
hasTaxon
Taxonomy Homo sapiens
isPartOf
KEGG Pathway Parkinson's disease
hasVersion
Human Disease Ontology neurodegenerative disease
hasProperty
Human Disease Ontology Parkinson's disease
Curation status
Curated
Original model(s)
Proctor_UCHL1_PD
  • Model originally submitted by : Carole Proctor
  • Submitted: Dec 7, 2009 1:19:38 PM
  • Last Modified: Apr 8, 2016 5:54:30 PM
Revisions
  • Version: 2 public model Download this version
    • Submitted on: Apr 8, 2016 5:54:30 PM
    • Submitted by: Carole Proctor
    • With comment: Current version of Proctor2010 - UCHL1 Protein Aggregation
  • Version: 1 public model Download this version
    • Submitted on: Dec 7, 2009 1:19:38 PM
    • Submitted by: Carole Proctor
    • With comment: Original import of BIOMD0000000293.xml.origin
Curator's comment:
(added: 10 Jan 2011, 13:49:21, updated: 10 Jan 2011, 13:49:21)
Figure 2 of the reference publication has been reproduced here. The model was integrated and simulated using Copasi v4.6 (Build 32). Stochastic (Gibson + Bruck) Method was used to simulated the model.